份子癌症研讨 SCIE

期刊简介估计审稿时候： 偏慢,4-8周

Molecular Cancer Research publishes articles describing novel basic cancer research discoveries of broad interest to the field. Studies must be of demonstrated significance, and the journal prioritizes analyses performed at the molecular and cellular level that reveal novel mechanistic insight into pathways and processes linked to cancer risk, development, and/or progression. Areas of emphasis include all cancer-associated pathways (including cell-cycle regulation; cell death; chromatin regulation; DNA damage and repair; gene and RNA regulation; genomics; oncogenes and tumor suppressors; signal transduction; and tumor microenvironment), in addition to studies describing new molecular mechanisms and interactions that support cancer phenotypes. For full consideration, primary research submissions must provide significant novel insight into existing pathway functions or address new hypotheses associated with cancer-relevant biologic questions.

《份子癌症研讨》颁发的文章描写了该范畴普遍存眷的新型根本癌症研讨发明。研讨必须具备明显意思，该期刊优先斟酌在份子和细胞程度上停止的阐发，这些阐发揭露了与癌症危险、成长和/或停顿相干的路子和进程的新机制看法。重点范畴包含一切与癌症相干的路子（包含细胞周期调控；细胞灭亡；染色质调控；DNA 毁伤和修复；基因和 RNA 调控；基因组学；致癌基因和肿瘤按捺因子；旌旗灯号转导；和肿瘤微环境），和描写撑持癌症表型的新份子机制和彼此感化的研讨。为了取得充实斟酌，首要研讨提交必须供给对现有路子功效的严重新看法或处理与癌症相干的生物学题目相干的新假定。

《Molecular Cancer Research》(份子癌症研讨)编辑部通信体例为AMER ASSOC CANCER RESEARCH, 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, USA, PA, 19106-4404。若是您须要辅佐投稿或润稿办事，您可以或许征询咱们的客服教员。咱们专一于期刊征询办事十年，熟习颁发政策，可为您供给一对一投稿指点，防止您在投稿时频仍碰鼻，节流您的可贵时候，有用晋升颁发机率，确保SCI检索（检索不了全额退款）。咱们视诺言为生命，多方面确保文章宁静失密，在任何环境下都不会泄漏您的小我信息或稿件内容。